Introducing SHL Pharma: A Greener Approach
pharmafile | June 29, 2011 | News story | Manufacturing and Production |Â Â auto injector, autoinjector, automation, final assembly, final packagingÂ
SHL Group is proud to introduce SHL Pharma, a facility built with a greener approach providing final assembly, labeling and packaging services of drug delivery devices such as autoinjectors for the pharmaceutical and biotechnology industries.
The addition of SHL Pharma means we can now take projects from design to distribution, providing a business model that makes even more sense for our customers. To ensure the automation equipment in-house are designed to accommodate specific assembly needs, many of the machines have also been built by SHL Automation. As a result, special details related to the device’s assembly can be communicated and integrated into the machine design.
Constructed with LEED practices:
Promoting Greener concepts and implementations is an ongoing effort at SHL and can be seen at the brand new SHL Pharma facility, where LEED (Leadership in Energy and Environmental Design) guidelines have been implemented.
Some of the many LEED practices we are focusing on include the following:
– Optimizing Energy Performance
– Encouraging Alternative Transportation
– Water Use Reduction
– Construction Waste Management
– Indoor Air Quality / Low-Emitting Material
– Rapidly Renewable Materials
It is part of SHL’s company strategy to be an environmentally responsible corporation and we will continue to encourage and develop new improvement goals for our global operations to incorporate sustainable practices wherever and whenever possible.
Related Content
Scitech Engineering joins Ekium Group, rebrands as Scitech-EKIUM
Scitech Engineering, a provider of engineering and manufacturing services across multiple industries including life sciences, …
Novartis secures US rights to Adamis’ epinephrine auto injector
Novartis has penned an agreement with Adamis Pharmaceuticals to commercialise and distribute the latter’s epinephrine …
FDA unveils guidelines to help generic medical device versions reach the market
The scandal surrounding Mylan’s price-hiking of its flagship EpiPen epinephrine auto-injector was the news of …
